Maviret is an antiviral medicine used to treat adults and children from 3 years of age with chronic (long-term) hepatitis C, an infectious disease that affects the liver, which is caused by the hepatitis C virus. Maviret contains the active substances glecaprevir and pibrentasvir.
Therapeutic Indication
### Therapeutic indication Maviret is indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults and children aged 3 years and older. Maviret coated granules is indicated for the treatment of chronic hepatitis C virus (HCV) infection in children 3 years and older.
Therapeutic Area (MeSH)
N/AATC Code
J05AP57
ATC Item
glecaprevir and pibrentasvir
Pharmacotherapeutic Group
Antivirals for systemic use
Active Substance (Summary)
N/AINN / Common Names
N/A| Substance | CAS | Monograph |
|---|---|---|
| glecaprevir | N/A | 格卡瑞韦 |
| pibrentasvir | N/A | Pibrentasvir |
EMA Name
Maviret
Medicine Name
Maviret
Aliases
N/ANo risk management plan link.
